Skip to main content

Table 1 Baseline characteristics of participants

From: Association between atherogenic index of plasma and prehypertension or hypertension among normoglycemia subjects in a Japan population: a cross-sectional study

 

Quartiles of AIP

Variable

Total

Q1(≤—0.37)

Q2(-0.37–0.15)

Q3(0.15–0.73)

Q4(≥ 0.73)

P value

Included participants

15,453

3,863

3,863

3,861

3866

 

Sex, n (%)

     

< 0.001

 Female

7034 (45.5)

2951 (76.4)

2155 (55.8)

1355 (35.1)

573 (14.8)

 

 Male

8419 (54.5)

912 (23.6)

1708 (44.2)

2506 (64.9)

3293 (85.2)

 

Age, years

43.7 ± 8.9

41.3 ± 8.4

43.4 ± 8.9

45.0 ± 9.1

45.2 ± 8.7

< 0.001

WC, cm

76.5 ± 9.1

70.6 ± 7.0

73.9 ± 7.9

78.0 ± 8.2

83.4 ± 8.0

< 0.001

Weight, kg

60.6 ± 11.6

53.3 ± 8.4

57.7 ± 9.9

62.3 ± 10.5

69.3 ± 11.1

< 0.001

BMI, kg/m2

22.1 ± 3.1

20.3 ± 2.3

21.4 ± 2.6

22.5 ± 2.9

24.3 ± 3.1

< 0.001

Smoking, n (%)

     

< 0.001

 Never

9027 (58.4)

3032 (78.5)

2530 (65.5)

1981 (51.3)

1484 (38.4)

 

 Past

2949 (19.1)

480 (12.4)

672 (17.4)

840 (21.8)

957 (24.8)

 

 Current

3477 (22.5)

351 (9.1)

661 (17.1)

1040 (26.9)

1425 (36.9)

 

Alcohol, n (%)

     

< 0.001

 None

11802 (76.4)

3264 (84.5)

3007 (77.8)

2854 (73.9)

2677 (69.2)

 

 Light

1754 (11.4)

317 (8.2)

432 (11.2)

492 (12.7)

513 (13.3)

 

 Moderate

1357 (8.8)

225 (5.8)

311 (8.1)

361 (9.3)

460 (11.9)

 

 Heavy

540 (3.5)

57 (1.5)

113 (2.9)

154 (4)

216 (5.6)

 

Exercise, n (%)

     

< 0.001

 No

12747 (82.5)

3133 (81.1)

3178 (82.3)

3161 (81.9)

3275 (84.7)

 

 Yes

2706 (17.5)

730 (18.9)

685 (17.7)

700 (18.1)

591 (15.3)

 

Fatty liver, n (%)

     

< 0.001

 No

12716 (82.3)

3781 (97.9)

3577 (92.6)

3164 (81.9)

2194 (56.8)

 

 Yes

2737 (17.7)

82 (2.1)

286 (7.4)

697 (18.1)

1672 (43.2)

 

ALT, IU/L

20.0 ± 14.3

15.1 ± 7.6

17.0 ± 8.9

20.2 ± 11.4

27.5 ± 21.6

< 0.001

AST, IU/L

18.4 ± 8.6

17.1 ± 6.7

17.4 ± 6.0

18.3 ± 7.0

20.9 ± 12.6

< 0.001

GGT, IU/L

20.3 ± 18.1

14.3 ± 9.9

16.8 ± 12.3

21.5 ± 19.0

28.7 ± 24.2

< 0.001

HDL-C, mg/dL

56.5 ± 15.6

71.2 ± 14.7

60.7 ± 11.3

52.2 ± 9.9

42.0 ± 8.2

< 0.001

TC, mg/dL

198.2 ± 33.4

188.2 ± 31.1

193.9 ± 31.4

200.0 ± 33.2

210.7 ± 33.7

< 0.001

TG, mg/dL

65.0(44.0,99.0)

34.0(27.0,41.0)

54.0(47.0,62.0)

79.0(68.0,91.0)

135.0(110.0–173.0)

< 0.001

HbA1, %

5.2 ± 0.3

5.1 ± 0.3

5.1 ± 0.3

5.2 ± 0.3

5.2 ± 0.3

< 0.001

FPG, mg/dL

93.0 ± 7.4

89.6 ± 7.1

91.9 ± 7.2

94.0 ± 7.0

96.3 ± 6.7

< 0.001

SBP, mmHg

114.5 ± 15.0

108.4 ± 13.1

112.0 ± 14.2

116.3 ± 14.5

121.1 ± 14.9

< 0.001

DBP, mmHg

71.6 ± 10.5

67.1 ± 9.3

69.7 ± 9.9

73.0 ± 10.1

76.6 ± 10.3

< 0.001

Prehypertension, n (%)

     

< 0.001

 No

11175 (72.3)

3228 (83.6)

2990 (77.4)

2640 (68.4)

2317 (59.9)

 

 Yes

4278 (27.7)

635 (16.4)

873 (22.6)

1221 (31.6)

1549 (40.1)

 

Hypertension, n (%)

     

< 0.001

 No

14491 (93.8)

3784 (98.0)

3710 (96.0)

3584 (92.8)

3413 (88.3)

 

 Yes

962 (6.2)

79 (2.0)

153 (4.0)

277 (7.2)

453 (11.7)

 

AIP

0.2 ± 0.8

-0.8 ± 0.3

-0.1 ± 0.1

0.4 ± 0.2

1.2 ± 0.4

< 0.001

  1. Data presented are mean ± SD, median (IQR), or N (%); Q1, Q2, Q3, and Q4 are quartiles of the Atherogenic Index of Plasma (AIP), WC Waist circumference, BMI Body mass index, ALT Alanine aminotransferase, AST Aspartate aminotransferase, GGT Gamma glutamyl transferase, HDL-C High-density lipoprotein cholesterol, TC Total cholesterol, TG Triglyceride, HbA1, Hemoglobin A1c, FPG Fasting plasma glucose, SBP Systolic blood pressure, DBP Diastolic blood pressure, AIP Atherogenic index of plasma